China Bioligic Products Holdings Inc (CBPO) Actualités

Confidential Treatment Order (ct Order)

Amended Statement of Beneficial Ownership (sc 13d/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule...

Amended Statement of Beneficial Ownership (sc 13d/a)

SECURITIES AND EXCHANGE COMMISSION   Washington, D.C. 20549       SCHEDULE...

Amended Statement of Beneficial Ownership (sc 13d/a)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE...

Amended Statement of Beneficial Ownership (sc 13d/a)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Amended Statement of Beneficial Ownership (sc 13d/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

  As filed with the Securities and Exchange Commission on April 21, 2021 Registration No. 333-238124  ...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

  As filed with the Securities and Exchange Commission on April 21, 2021 Registration No. 333-151263  ...

Amended Statement of Ownership: Private Transaction (sc 13e3/a)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File...

China Biologic Announces Completion of Going Private Transaction

China Biologic Announces Completion of Going Private Transaction PR Newswire BEIJING, April 20, 2021 BEIJING, April 20, 2021 /PRNewswire/...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

        UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2020

China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2020 PR Newswire BEIJING, March 29, 2021 BEIJING, March 29, 2021...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549    ...

China Biologic Announces Shareholders' Approval of Merger Agreement

China Biologic Announces Shareholders' Approval of Merger Agreement PR Newswire BEIJING, March 1, 2021 BEIJING, March 1, 2021 /PRNewswire/...